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Ethnic Inequalities in
Cancer Survival in New
Zealand: Linkage Study
| Mona Jeffreys, PhD, Vladimir Stevanovic, MD,
Martin Tobias, MBBCh, FAFPHM, Chris Lewis,
BSc(Hons), Lis Ellison-Loschmann, PhD, Neil
Pearce, PhD, DSc, and Tony Blakely, PhD
We explored the contribution of
stage at diagnosis to ethnic dispari-
ties in cancer survival in New
Zealand. We linked 115811 adult pa-
tients with invasive cancer registered
on the cancer registry (1994 to 2002)
to mortality data. Age-standardized,
5-year relative survival rates were
lowest for Maori, intermediate for
Pacific people (otherwise known as
Pacific Islanders), and highest for
non-Maori/non-Pacific people for
many cancers. Stage at diagnosis
accounted for only part of these dif-
ferences. Possible factors responsi-
ble for ethnic inequalities might in-
clude access to specialized cancer
services and the quality of care re-
ceived. (Am J Public Health. 2005;
95:834–837. doi:10.2105/AJPH.2004.
053678)
The ethnic mix of the more than 4 million
people of New Zealand includes the indige-
nous Maori (15% of the population) and
Pacific Islanders (7%), originally from the
South Pacific islands (hereafter referred to as
Pacific people). The majority of non-Maori/
non-Pacific people are of European descent.
The Treaty of Waitangi (1840) was a formal
agreement between Maori hapu (subtribes)
and the British Crown, which guaranteed
equity between Maori and other New
Zealand citizens.1 Because health rights are
implicit in the treaty,2 the poor health status
of Maori3 can be considered a breach of
their rights under the treaty.4
Since 1980, ethnic disparities in cancer
mortality have widened.5 These inequalities
cannot be explained by the differences in in-
cidence6,7 and point to likely differences in ac-
cess to and quality of health care.8 The few
studies that have examined ethnic inequalities
in cancer survival in New Zealand9–11 did not
account for background (other cause) mortal-
ity rates. Our goal was to quantify the dispari-
ties and to estimate the magnitude of the
contribution of stage of disease to these
inequalities.
METHODS
Adult patients (aged 15 to 99 years) who
had a cancer registered in the New Zealand
Cancer Registry between July 1, 1994, and
June 30, 2002, were identified (n=124599).
We restricted the analyses to 20 main sites (n=
118188) and excluded patients with (1) death
certificate only registrations (n=2345, 2.0%),
(2) in situ cancer (n=7, <0.1%), or (3) a
home address overseas (n=25, <0.1%).
We used the National Health Index, which
uniquely identifies health care users, to obtain
mortality data to June 2003. We used a Maori,
Pacific, non-Maori/non-Pacific–prioritized sys-
tem of assigning ethnicity12 that is based on
hospitalization and health administration
data, as is standard in New Zealand. Patients
with missing ethnicity data (2.6%) were ana-
lyzed with the non-Maori/non-Pacific group.
We used SURV3 software13 to estimate rel-
ative survival rates (RSRs)14 and standard er-
rors15,16 based on ethnic-specific life tables by
single year of age (15 to 99 years) from the
1996 census. Survival probabilities were esti-
mated at yearly intervals.
RSRs were directly standardized first for
age (15–44, 45–54, 55–64, 65–74, and
75–99 years) and then for disease stage
(local, regional, distant spread).17 Pacific peo-
ple were omitted from stage-standardized
analyses because of their small numbers.
We compared the age-standardized to the
age- and stage-standardized Maori to non-
Maori/non-Pacific RSR ratio to determine
the contribution of stage to the survival
inequalities.
RESULTS
Among 115811 patients, site-specific 5-
year RSRs (Table 1) showed lower survival
for Maori than for non-Maori/non-Pacific
people at many sites, including cancer of the
breast, cervix, colon/rectum, lung, prostate,
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TABLE 1—Age-Standardized 5-Year Relative Survival Rates (RSR), by Ethnicity and Cancer Site: 
New Zealand, 1994 to 2002
Maori Pacific Non-Maori/non-Pacific
Site (ICD-10 codes) No. of Cancers RSR (95% CI) No. of Cancers RSR (95% CI) No. of Cancers RSR (95% CI)
Bladder (C67) 100 0.58 (0.46, 0.71) 35 0.68 (0.44, 0.92) 4157 0.69 (0.67, 0.71)
Brain (C71) 80 0.24 (0.15, 0.33) 37 0.30 (0.18, 0.42) 1541 0.16 (0.14, 0.17)
Breast (C50) 1394 0.74 (0.71, 0.78) 448 0.71 (0.66, 0.77) 14925 0.81 (0.80, 0.82)
Cervix (C53) 316 0.63 (0.57, 0.69) 65 0.56 (0.42, 0.70) 1272 0.75 (0.72, 0.77)
Colon/rectum (C18–C21) 574 0.41 (0.36, 0.47) 203 0.53 (0.44, 0.62) 18850 0.60 (0.59, 0.61)
Esophagus (C15) 88 0.06 (0.01, 0.11) 16 0.40 (0.19, 0.61) 1443 0.11 (0.09, 0.13)
Head and neck, larynx (C01–C14, C32) 178 0.53 (0.43, 0.63) 96 0.64 (0.51, 0.76) 2064 0.56 (0.53, 0.59)
Kidney, uterus, urethra (C64–C66, C68) 159 0.46 (0.37, 0.56) 44 0.60 (0.44, 0.76) 2407 0.56 (0.53, 0.59)
Leukemia (C91–C95) 234 0.38 (0.30, 0.46) 105 0.42 (0.31, 0.54) 3523 0.46 (0.44, 0.48)
Liver (C22) 194 0.07 (0.03, 0.11) 114 0.18 (0.10, 0.25) 672 0.11 (0.08, 0.13)
Lung, trachea, bronchus (C33–C34) 1562 0.06 (0.04, 0.07) 353 0.22 (0.17, 0.27) 9712 0.10 (0.10, 0.11)
Melanoma (C43) 111 0.93 (0.83, 1.00) 24 0.92 (0.75, 1.09) 12791 0.91 (0.90, 0.92)
Non-Hodgkin’s lymphoma (C82–C85, C96) 236 0.48 (0.40, 0.56) 117 0.54 (0.43, 0.66) 3949 0.51 (0.49, 0.53)
Ovary (C56) 182 0.60 (0.52, 0.68) 83 0.51 (0.40, 0.62) 1979 0.42 (0.40, 0.45)
Pancreas (C25) 182 0.09 (0.04, 0.14) 48 0.46 (0.28, 0.63) 2063 0.04 (0.03, 0.05)
Pleura, thymus, heart (C37–C38) 20 0.11 (0.00, 0.27) 13 0.63 (0.41, 0.86) 152 0.26 (0.18, 0.34)
Prostate (C61) 723 0.69 (0.62, 0.75) 326 0.83 (0.75, 0.92) 19587 0.83 (0.82, 0.84)
Stomach (C16) 379 0.19 (0.14, 0.24) 165 0.35 (0.26, 0.43) 2386 0.18 (0.16, 0.20)
Thyroid gland (C73) 133 0.87 (0.80, 0.95) 102 0.97 (0.90, 1.03) 861 0.91 (0.88, 0.94)
Uterus (C54–C55) 210 0.62 (0.54, 0.70) 157 0.77 (0.68, 0.85) 1871 0.75 (0.72, 0.77)
Note. ICD-10 = International Classification of Diseases, 10th Revision,18 95% CI = 95% confidence interval; RSR = 5-year relative survival rate, estimated using ethnic-specific life tables. Analysis
based on all patients (with and without) stage data recorded on the New Zealand Cancer Registry, n = 115 811.
and uterus. Ovarian cancer survival was
higher in Maori compared with non-Maori/
non-Pacific women. Survival among Pacific
people was lower than non-Maori/non-Pacific
people for colorectal, breast, and cervical
cancer and higher for lung cancer. There
were no differences by gender (results not
shown).
The survival pattern among the patients
with missing stage data (35%) differed by
site, but age-standardized RSRs were similar
between the total population and those
patients with recorded stage data (Tables 1
and 2). Following standardization for stage,
the RSRs for Maori and non-Maori/
non-Pacific people were close for cancers
of the breast and prostate. However, stage
at diagnosis explained little of the survival
disparities for cancers of the bladder, cervix,
colorectum, head/neck/larynx, lung, or
uterus. The apparent survival advantage
among Maori for ovarian cancer was fully
explained by stage.
DISCUSSION
Stage at diagnosis explains some but not all
of the ethnic differences in cancer survival in
New Zealand. Residual confounding through
inaccuracies in stage classification could ex-
plain some of the results. Although little bias
appears to have been introduced through
exclusion of people with missing stage data.
Differential access to health services and
health system factors are likely to contribute
to the remaining disparities.
Because cancer and death registration are
mandatory, selective underascertainment is
unlikely to explain the results. Using priori-
tized ethnicity, misclassification of Maori and
Pacific ethnicity19 would underestimate the
differences in survival between ethnic groups.
Selective migration of terminally ill Pacific
cancer patients to the Pacific would artifi-
cially inflate their survival rate, which may
explain some of our results. Higher comor-
bidities in Maori, which could limit treatment
options, might account for some of the ob-
served differences.
Biological or genetic differences cannot ac-
count for ethnic differences in health.20 The
unequal distribution of socioeconomic posi-
tion by ethnicity may explain some, but prob-
ably not all,21–23 of the survival differences.
In the United States, similar outcomes are ex-
perienced by people of different ethnicities in
equal-access settings24; in other settings, the
quality of cancer treatment differs by ethnic-
ity.8 Health care utilization by Maori is not
proportional to the expected need,3 which
suggests that Maori are medically under-
served in New Zealand.25 Factors that influ-
ence the receipt of optimal health care in-
clude cost,26 access through the secondary
care system,27,28 rurality,10 and cultural
safety,29 including perceived attitudes of
health workers and acceptability of health
providers to Maori.3,28 Maori-led health ser-
vices may provide more acceptable opportu-
nities for appropriate care for some Maori.30
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TABLE 2—Age- and Age- and Stage-Standardized 5-Year Relative Survival Rates (RSR), by Ethnicity 
and Cancer Site: New Zealand, 1994 to 2002
Age-Standardized Age- and Stage-Standardized
Maori Non-Maori/non-Pacific Maori Non-Maori/non-Pacific
Site (ICD-10 codes) No. of Cancers RSR (95% CI) No. of Cancers RSR (95% CI) RSRR RSR (95% CI) RSR (95% CI) RSRR
Bladder (C67) 32 0.36 (0.20, 0.52) 945 0.55 (0.50, 0.69) 0.65 0.37 (0.22, 0.51) 0.54 (0.50, 0.58) 0.69
Brain (C71) 64 0.27 (0.17, 0.37) 1297 0.16 (0.14, 0.18) 1.69 0.18 (0.11, 0.25) 0.17 (0.15, 0.19) 1.06
Breast (C50) 1154 0.76 (0.72, 0.79) 11965 0.82 (0.81, 0.83) 0.93 0.81 (0.76, 0.87) 0.82 (0.81, 0.83) 0.99
Cervix (C53) 193 0.73 (0.66, 0.79) 846 0.87 (0.84, 0.89) 0.84 0.74 (0.69, 0.79) 0.85 (0.83, 0.87) 0.87
Colon/rectum (C18–C21) 484 0.43 (0.37, 0.50) 16729 0.61 (0.60, 0.62) 0.70 0.44 (0.35, 0.53) 0.61 (0.60, 0.62) 0.72
Esophagus (C15) 28 No survivors 549 0.12 (0.09, 0.16) . . . No survivors 0.12 (0.09, 0.15) . . .
Head and neck, larynx (C01–C14, C32) 101 0.46 (0.32, 0.59) 1136 0.54 (0.50, 0.58) 0.85 0.38 (0.27, 0.49) 0.54 (0.51, 0.58) 0.70
Kidney, uterus, urethra (C64–C66, C68) 135 0.52 (0.42, 0.63) 1972 0.59 (0.56, 0.62) 0.88 0.49 (0.34, 0.63) 0.59 (0.57, 0.62) 0.83
Liver (C22) 60 0.02 (0.00, 0.60) 226 0.11 (0.06, 0.15) 0.18 0.05 (0.00, 0.12) 0.14 (0.09, 0.18) 0.36
Lung, trachea, bronchus (C33–C34) 716 0.06 (0.04, 0.08) 4786 0.11 (0.10, 0.12) 0.55 0.06 (0.03, 0.09) 0.11 (0.10, 0.12) 0.55
Melanoma (C43) 104 0.94 (0.84, 1.00) 12302 0.91 (0.90, 0.92) 1.02 0.97 (0.81, 1.00) 0.91 (0.90, 0.92) 1.06
Ovary (C56) 167 0.60 (0.52, 0.69) 1793 0.42 (0.39, 0.44) 1.43 0.42 (0.28, 0.56) 0.43 (0.41, 0.45) 0.98
Pancreas (C25) 108 0.09 (0.03, 0.15) 1138 0.05 (0.03, 0.06) 1.80 0.05 (0.01, 0.09) 0.05 (0.03, 0.06) 1.00
Pleura, thymus, heart (C37–C38) 6 0.19 (0.00, 0.46) 71 0.33 (0.21, 0.45) 0.58 0.07a 0.27 (0.19, 0.35) 0.26
Prostate (C61) 197 0.54 (0.44, 0.65) 4884 0.73 (0.71, 0.74) 0.74 0.66 (0.55, 0.76) 0.71 (0.70, 0.73) 0.93
Stomach (C16) 259 0.20 (0.14, 0.26) 1543 0.22 (0.19, 0.24) 0.91 0.15 (0.10, 0.20) 0.22 (0.20, 0.25) 0.68
Thyroid gland (C73) 120 0.87 (0.79, 0.95) 747 0.93 (0.90, 0.95) 0.94 0.86 (0.81, 0.91) 0.92 (0.89, 0.94) 0.93
Uterus (C54–C55) 169 0.65 (0.56, 0.74) 1555 0.77 (0.74, 0.80) 0.84 0.48 (0.40, 0.57) 0.77 (0.74, 0.79) 0.62
Note. ICD-10 = International Classification of Diseases, 10th Revision,18 95% CI = 95% confidence interval; RSR = 5-year relative survival rate, estimated using ethnic-specific life tables;
RSRR = Maori to non-Maori/non-Pacific RSR ratio. Analysis based on all patients with stage data recorded on the New Zealand Cancer Registry, n = 68 581.This table excludes leukemia and non-
Hodgkin’s lymphoma, because surveillance, epidemiology, and end results (SEER) summary staging data are not available for these sites.
aCI not included because data corresponds to a single individual.
To tackle these documented inequalities,
it is necessary to pinpoint where on the can-
cer continuum inequalities arise. Survival
disparities also could be reduced by ad-
dressing structural and service barriers
within the health sector and by ensuring a
commitment, with sufficient funding, to
strengthen the Maori and Pacific health
workforces.
About the Authors
Mona Jeffreys, Lis Ellison-Loschmann, and Neil Pearce are
with the Centre for Public Health Research, Massey Uni-
versity, Wellington, New Zealand. Vladimir Stevanovic
and Chris Lewis are with the New Zealand Health Infor-
mation Service, Wellington. Martin Tobias is with the
Public Health Intelligence, Ministry of Health, Wellington.
Tony Blakely is with the Department of Public Health,
Wellington School of Medicine and Health Sciences, Uni-
versity of Otago, Wellington.
Requests for reprints should be sent to Mona Jeffreys,
PhD, Centre for Public Health Research, Massey Univer-
sity, Private Bag 756, Wellington, New Zealand (e-mail:
m.jeffreys@massey.ac.nz).
This article was accepted December 11, 2004.
Contributors
M. Jeffreys, V. Stevanovic, and N. Pearce developed
the study. C. Lewis and V. Stevanovic performed the
linkage. V. Stevanovic and M. Jeffreys performed
the data analyses. T. Blakely, M. Tobias, V. Stevanovic,
and M. Jeffreys participated in initial discussions of the
results. M. Jeffreys wrote the first draft. All authors
contributed to subsequent drafts and the final brief.
The discussions of indigenous health were contributed
primarily by L. Ellison-Loschmann.
Acknowledgments
We gratefully acknowledge the financial support of the
Lottery Health Research, who funded the salary for 1
of us (MJ) to carry out this work (grant AP102396).
The Centre for Public Health Research is supported by
a programme grant from the Health Research Council
of New Zealand.
We are indebted to the hard work of staff at the
New Zealand Cancer Registry.
Note. Neither Lottery Health Research nor the Health
Research Council of New Zealand had any involvement
in the data collection, analysis, or writing of the brief.
Human Participant Protection
Formal protocol approval was not sought because the
study involved only anonymous linkage between 2
databases.
References
1. Durie M. Whaiora: Maori Health Development.
Auckland, New Zealand: Oxford University Press;
1994.
2. Durie MH. Te mana Te Kawanatanga: The Politics
of Maori Self-Determination. Auckland, New Zealand:
Oxford University Press; 1998.
3. Pomare E, Keefe-Ormsby V, Ormsby C, et al.
Hauora. Maori Standards of Health III. A Study of the
Years 1970–1991. Wellington, New Zealand: Te Ropu
Rangahau Hauora a Eru Pomare; 1995.
4. Robson B, Reid P. Ethnicity Matters: Maori Per-
spectives. Review of the Measurement of Ethnicity.
Wellington, New Zealand: Statistics New Zealand;
2001.
5. Ajwani S, Blakely T, Robson B, Tobias M, Bonne M.
Decades of Disparity: Ethnic Mortality Trends in New
Zealand 1980–1999. Wellington, New Zealand: Min-
istry of Health and University of Otago; 2003.
6. New Zealand Ministry of Health. Cancer in New
Zealand: Trends and Projections. Wellington, New
Zealand: New Zealand Ministry of Health; 2002. Pub-
lic Health Intelligence Occasional Bulletin No. 15.
7. Foliaki S, Jeffreys M, Wright C, Blakey K, Pearce N.
Cancer in Pacific people in New Zealand: a descriptive
study. Pac Health Dialog. 2005. In press.
8. Smedley B, Stith A, Nelson A, eds. Unequal Treat-
May 2005, Vol 95, No. 5 | American Journal of Public Health Jeffreys et al. | Peer Reviewed | Research and Practice | 837
 RESEARCH AND PRACTICE 
ment: Confronting Racial and Ethnic Disparities in Health
Care. Washington, DC: National Academy Press; 2002.
9. Lethaby AE, Mason BH, Holdaway IM, Kay RG.
Age and ethnicity as prognostic factors influencing
overall survival in breast cancer patients in the Auck-
land region. Auckland Breast Cancer Study Group. N Z
Med J. 1992;105(947):485–488.
10. Gill AJ, Martin IG. Survival from upper gastroin-
testinal cancer in New Zealand: The effect of distance
from a major hospital, socio-economic status, ethnicity,
age and gender. ANZ J Surg. 2002;72:643–646.
11. Phillips AR, Lawes CM, Cooper GJ, Windsor JA.
Ethnic disparity of pancreatic cancer in New Zealand.
Int J Gastrointest Cancer. 2002;31(1–3):137–145.
12. New Zealand Department of Statistics. Ethnicity in
New Zealand: Recommendations for a Standard Classifi-
cation. Discussion paper. Wellington, New Zealand:
New Zealand Department of Statistics; 1990.
13. Dickman P, Hakulinen T, Voutilainen E. SURV3:
Relative Survival Analysis [computer program]. v3.00.
Helsinki, Finland: Finnish Cancer Registry; 2002.
14. Esteve J, Benhamou E, Croasdale M, Raymond L.
Relative survival and the estimation of net survival:
elements for further discussion. Stat Med. 1990;9:
529–538.
15. Greenwood M. The Natural Duration of Cancer.
London, England: HMSO; 1926. Report on Public
Health and Medical Subjects No. 33
16. Capocaccia R, Gatta G, Roazzi P, et al. The
EUROCARE-3 database: methodology of data collec-
tion, standardisation, quality control and statistical
analysis. Ann Oncol. 2003;14(suppl 5):v14–v27.
17. Young JL Jr, Roffers SD, Ries LAG, Fritz AG,
Hurlbut AA, eds. SEER Summary Staging Manual—
2000: Codes and Coding Instructions. Bethesda, MD: Na-
tional Cancer Institute; 2001. NIH Pub. No. 01-4969.
18. International Classification of Diseases, 10th Revi-
sion. Geneva, Switzerland: World Health Organization;
1992.
19. Ajwani S, Blakely T, Robson B, Atkinson J, Kiro C.
Unlocking the numerator-denominator bias III: adjust-
ment ratios by ethnicity for 1981–1999 mortality data.
The New Zealand Census-Mortality Study. N Z Med J.
2003;116(1175):U456.
20. Pearce N, Foliaki S, Sporle A, Cunningham C.
Genetics, race, ethnicity and health. BMJ. 2004;328:
1070–1072.
21. Pearce N, Pomare E, Marshall S, Borman B. Mor-
tality and social class in Maori and non-Maori New
Zealand men: changes between 1975–7 and 1985–7.
N Z Med J. 1993;106:193–196.
22. Salmond C, Crampton P. Deprivation and Health.
In: Howden-Chapman PTM, ed. Social Inequalities in
Health: New Zealand 1999. Wellington, New Zealand:
Ministry of Health; 2000:9–64.
23. Blakely T, Kiro C, Woodward A. Unlocking the
numerator-denominator bias. II: Adjustments to mortal-
ity rates by ethnicity and deprivation during 1991–94.
The New Zealand Census-Mortality Study. N Z Med J.
2002;115(1147):43–48.
24. Shavers VL, Brown ML. Racial and ethnic dispari-
ties in the receipt of cancer treatment. J Natl Cancer
Inst. 2002;94:334–357.
25. Malcolm L. Inequities in access to and utilisation
of primary medical care services for Maori and low in-
come New Zealanders. N Z Med J. 1996;109(1030):
356–358.
26. Schoen C, Blendon R, DesRoches C, Osborn R,
Doty M, Downey D. New Zealand Adults’ Health Care
System Views and Experiences, 2001. Findings From the
Commonwealth Fund 2001 International Health Policy
Survey. New York, NY: The Commonwealth Fund;
2002. Report No. 553.
27. Baxter J. Eight Health Gain Priority Areas for
Maori Health. Report 1: Mental Health. A Report Pre-
pared for the Maori Health Group, Health Funding Au-
thority. Auckland, New Zealand: Health Funding Au-
thority; 2000.
28. Baxter J. Barriers to Health Care for Maori with
Known Diabetes: A Literature Review and Summary of
Issues. Wellington, New Zealand: New Zealand Na-
tional Working Group on Diabetes; 2002.
29. Trans-HHS Cancer Health Disparities Progress
Review Group. Making Cancer Health Disparities His-
tory. Washington, DC: US Department of Health and
Human Services; 2004.
30. Ellison-Loschmann L, Pearce N. He Mate Huango:
an update on Maori asthma. Pac Health Dialog. 2000;
7:82–93.
